SUPRAN BRYAN
SEC CIK 1511797 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | EVP, CLO, Sec | 14.6K | — | — | 2 | 2025-10-01 | 2026-03-02 |
Most active insiders at ALNY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Greenstreet Yvonne | CEO, Dir | — | $24.46M |
| 2 | Fitzgerald Kevin Joseph | CSO, EVP, Head of Research | — | $10.74M |
| 3 | Garg Pushkal | EVP Chief R, D | — | $8.12M |
| 4 | Poulton Jeffrey V. | EVP, CFO | — | $4.95M |
| 5 | Tanguler Tolga | EVP, Chief Commercial Off | — | $3.06M |
| 6 | McLaughlin Melissa | CHRO | — | $1.27M |
| 7 | PYOTT DAVID E I | Dir | — | $1.15M |
| 8 | Reitan Colleen F | Dir | — | — |
| 9 | Sigal Charles Elliott | Dir | — | — |
| 10 | Arbuckle Stuart A | Dir | — | — |
| 11 | SUPRAN BRYAN | EVP, CLO, Sec | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-04 | 2026-03-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | SUPRAN BRYAN | EVP, CLO, Sec | A - Grant | $0.00 | +1,539 | 14.6K | +12% | $0 |
| 2025-10-03 | 2025-10-01 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | SUPRAN BRYAN | EVP, CLO, Sec | A - Grant | $0.00 | +13.0K | 13.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations